Letrozole
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Letrozole and local guidelines before prescribing.
Aromatase inhibitor
Mechanism
Aromatase inhibitor.
Uses
ER-positive breast cancer, ovulation induction (off-label).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hot flushes, arthralgia, osteoporosis, fatigue, raised lipids.
Interactions
Tamoxifen reduces levels.
Contraindications and cautions
Premenopausal state
Monitoring
Bone density, lipids
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Caution in severe hepatic impairment
Overdose and reversal
Supportive
Special advice
Bone density monitoring; calcium and vitamin D.
More from the textbook: uses, cautions and other points
- Fertility: Letrozole is now first-line for ovulation induction. Alternatives are clomifene, gonadotrophins, laparoscopic ovarian drilling and IVF.
Endocrinology: Reproductive - Letrozole PCOS subfertility | First-line ovulation induction (specialist).
Endocrinology: Reproductive - Fertility - weight loss; letrozole (first-line ovulation induction) or clomifene; metformin; IVF.
Gynaecology: Menstrual Disorders - Group II - hypothalamic–pituitary–ovarian dysfunction (normal FSH and oestrogen: mainly PCOS ) - weight loss; letrozole or clomifene (with ultrasound monitoring - multiple pregnancy risk); metformin; laparoscopic ovarian drilling; gonadotrophins; IVF.
Gynaecology: Fertility Contraception Menopause - Letrozole / clomifene | Ovulation induction (PCOS); multiple pregnancy risk - monitor.
Gynaecology: Fertility Contraception Menopause - Clomifene and letrozole - induce ovulation (PCOS - letrozole now often preferred); risk of multiple pregnancy and ovarian hyperstimulation.
Endocrine: Anatomy Physiology and Pharmacology - Anastrozole / letrozole | Joint pain, osteoporosis (DEXA, bisphosphonate).
Oncology: Principles - Anastrozole / letrozole | Postmenopausal ER-positive breast cancer; joint pain, bone loss; also prevention in high-risk women.
Oncology: Breast and Gynae Cancers
Where it is discussed in the book
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Reproductive (2 mentions)
- Oncology: Principles (1 mention)
- Oncology: Breast and Gynae Cancers (2 mentions)
- Gynaecology: Menstrual Disorders (2 mentions)
- Gynaecology: Fertility Contraception Menopause (3 mentions)